Transarterial chemoembolization as adjuvant treatment after surgery: The cure of huge hepatocellular carcinoma?

正Hepatocellular carcinoma(HCC) represents the sixth common cancer and the second leading cause of cancer-related death. Its incidence is higher in Eastern countries. HCC is frequently detected at advanced stage of disease, and therefore, the mortality is high [1].